Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Anti-TNF drugs in dermatology and inflammatory bowel disease - Where are we going? — Richard B. Warren (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Anti-TNF drugs in dermatology and inflammatory bowel disease - Where are we going?
Shared by
Christopher Em Griffiths
Anti-TNF drugs in dermatology and inflammatory bowel disease - Where are we going?
Article
2006
en
Authors
RW
Richard B. Warren
Christopher Em Griffiths
Related publications
Article
2006
Anti‐TNF drugs in psoriasis and IBD ‐ Where are we going?
Richard B. Warren
,
Christopher Em Griffiths
,
James O. Lindsay
Article
1994
What Are We? Where Did We Come From? Where Are We Going?
Luke O'neill
,
Michael Murphy
,
Richard B. Gallagher
Science
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2013
Critical care - where have we been and where are we going?
Jean Louis Vincent
Article
2017
Macrophage Immunometabolism: Where Are We (Going)?
Jan Van den Bossche
,
Luke O'neill
,
Deepthi Menon
Trends in Immunology
Article
2019
Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?
Andreas Kronbichler
,
Philipp Gauckler
,
Keum Hwa Lee
,
Jae Il Shin
,
Paolo Malvezzi
,
Gert Mayer
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.